In a series of 439 ERα-positive or ERα-negative breast tumors, representing the different molecular subtypes, large ranges of AHR (0–5.8-fold difference) and AHRR (0–19.8-fold difference) mRNA expression were observed, reflecting extensive heterogeneity of gene expression in tumor samples. This evidence concerns the gene ESR1 and neoplasm.